|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1996-8-22
|
|
pubmed:abstractText |
To avert major hemorrhage, physicians need to know the lowest intensity of anticoagulation that is effective in preventing stroke in patients with atrial fibrillation. Since the low rate of stroke has made it difficult to perform prospective studies to resolve this issue, we conducted a case-control study.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
335
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
540-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8678931-Adult,
pubmed-meshheading:8678931-Aged,
pubmed-meshheading:8678931-Anticoagulants,
pubmed-meshheading:8678931-Atrial Fibrillation,
pubmed-meshheading:8678931-Brain Ischemia,
pubmed-meshheading:8678931-Case-Control Studies,
pubmed-meshheading:8678931-Cerebrovascular Disorders,
pubmed-meshheading:8678931-Dose-Response Relationship, Drug,
pubmed-meshheading:8678931-Female,
pubmed-meshheading:8678931-Humans,
pubmed-meshheading:8678931-Male,
pubmed-meshheading:8678931-Middle Aged,
pubmed-meshheading:8678931-Odds Ratio,
pubmed-meshheading:8678931-Risk Factors,
pubmed-meshheading:8678931-Warfarin
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
|
|
pubmed:affiliation |
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
